NO830669L - Nye glykoproteiner, fremgangsmaater for deres fremstilling og terapeutiske preparater for tumorer som inneholder slike glykoproteiner - Google Patents

Nye glykoproteiner, fremgangsmaater for deres fremstilling og terapeutiske preparater for tumorer som inneholder slike glykoproteiner

Info

Publication number
NO830669L
NO830669L NO830669A NO830669A NO830669L NO 830669 L NO830669 L NO 830669L NO 830669 A NO830669 A NO 830669A NO 830669 A NO830669 A NO 830669A NO 830669 L NO830669 L NO 830669L
Authority
NO
Norway
Prior art keywords
cells
reaction
shows
phosphate buffer
hours
Prior art date
Application number
NO830669A
Other languages
English (en)
Norwegian (no)
Inventor
Haruo Ohnishi
Kazuo Yamaguchi
Yasuo Suzuki
Ei Mochida
Nobuo Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of NO830669L publication Critical patent/NO830669L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/828Cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO830669A 1982-02-26 1983-02-25 Nye glykoproteiner, fremgangsmaater for deres fremstilling og terapeutiske preparater for tumorer som inneholder slike glykoproteiner NO830669L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤

Publications (1)

Publication Number Publication Date
NO830669L true NO830669L (no) 1983-08-29

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830669A NO830669L (no) 1982-02-26 1983-02-25 Nye glykoproteiner, fremgangsmaater for deres fremstilling og terapeutiske preparater for tumorer som inneholder slike glykoproteiner

Country Status (17)

Country Link
US (1) US4481137A (fr)
BE (1) BE896027A (fr)
BR (1) BR8300933A (fr)
DD (1) DD209634A5 (fr)
DE (1) DE3306297A1 (fr)
DK (1) DK93383A (fr)
FI (1) FI830638L (fr)
FR (1) FR2522267A1 (fr)
GB (1) GB2117385B (fr)
GR (1) GR78097B (fr)
LU (1) LU84662A1 (fr)
NL (1) NL8300727A (fr)
NO (1) NO830669L (fr)
PL (1) PL240784A1 (fr)
PT (1) PT76296B (fr)
RO (1) RO85901B (fr)
SE (1) SE8301073L (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインiiiとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
WO1990000400A1 (fr) * 1988-07-15 1990-01-25 The Trustees Of Columbia University In The City Of New York Facteurs ameliorateurs de necrose tumorale et procedes de preparation et d'utilisation de tels facteurs
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度tcf製剤
US5641867A (en) 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び/又は治療剤
CA2253629A1 (fr) 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent preventif et/ou curatif de la cachexie
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
AU2004273783A1 (en) 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
ES2551922T3 (es) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Sistemas rápidos de purificación celular
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
EP3278115A2 (fr) 2015-03-30 2018-02-07 Accelerate Diagnostics, Inc. Instrument et système pour l'identification rapide de micro-organismes et test de la sensibilité à un agent antimicrobien
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
US4481137A (en) 1984-11-06
NL8300727A (nl) 1983-09-16
GB2117385B (en) 1985-05-09
PT76296A (en) 1983-03-01
LU84662A1 (fr) 1983-09-08
BR8300933A (pt) 1983-11-16
GB8305330D0 (en) 1983-03-30
DE3306297A1 (de) 1983-09-15
PT76296B (en) 1985-11-12
GB2117385A (en) 1983-10-12
DK93383D0 (da) 1983-02-25
DD209634A5 (de) 1984-05-16
RO85901B (ro) 1985-01-30
SE8301073L (sv) 1983-08-27
SE8301073D0 (sv) 1983-02-25
FR2522267A1 (fr) 1983-09-02
PL240784A1 (en) 1983-11-07
FI830638L (fi) 1983-08-27
DK93383A (da) 1983-08-27
FI830638A0 (fi) 1983-02-25
GR78097B (fr) 1984-09-26
RO85901A (fr) 1985-01-24
BE896027A (fr) 1983-08-25

Similar Documents

Publication Publication Date Title
NO830669L (no) Nye glykoproteiner, fremgangsmaater for deres fremstilling og terapeutiske preparater for tumorer som inneholder slike glykoproteiner
Sugimura et al. Carcinogenic action of N-methyl-N′-nitro-N-nitrosoguanidine
DK169479B1 (da) Fremgangsmåde til fremstilling af humanspecifikt type II-interferon
US4571336A (en) Immune stimulation
EP0159276A2 (fr) Facteur inhibiteur de croissance de tumeur substantiellement purifié
Fuhrman et al. Toxins from eggs of fishes and amphibia
US5187260A (en) Process for the preparation of a high purity protamine-DNA complex and process for use of same
Chang et al. Cellular immunity of mice to Leishmania donovani in vitro: lymphokine-mediated killing of intracellular parasites in macrophages.
Mendez et al. Effects of concanavalin A, fed as a constituent of Jack bean (Canavalia ensiformis L.) seeds, on the humoral immune response and performance of broiler chickens
US4180627A (en) Process for in vivo transfer of cell-mediated immunity in mammals with alcoholic precipitates of Bovine Transfer factor
JPS6011890B2 (ja) ツモアネクロシスフアクタ−の製造方法
US4442087A (en) Interferon inducer, a process for producing the same and pharmaceutical composition containing the same
EP1017406B1 (fr) Extraits d'excretion bovine a activite anticancereuse et anti-inflammatoire et leur procede de preparation
CN114209812B (zh) α-苦瓜素在制备抗炎药物中的用途
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
JPS59141519A (ja) 制ガン作用を有する蛋白質
US4676983A (en) Tumor cytostatic-citocidal factor from blood platelets
NO850152L (no) Fremgangsmaate ved fremstilling av human, endogen cancerregulerende faktor.
JPS5888322A (ja) 標的細胞障害性因子を含有する悪性腫瘍治療剤とその製造方法
KR960004028B1 (ko) 면역증강제 조성물
NO842015L (no) Immunstimulator
JP2532025B2 (ja) 新リンホカインiiiを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
KR890004692B1 (ko) 항종양 생리학적 활성물질의 정제방법
Chao et al. An in vivo model for the study of chemotaxis induced by schistosomula of Schistosoma mansoni
CN103271976A (zh) 一种用于防治家禽病毒性疾病的药物组合物